Medtronic (MDT) Tops Q2 EPS by 2c; Guides FY23 EPS Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Medtronic reports second quarter fiscal 2023 financial results
November 22, 2022 6:45 AM ESTEarnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes
DUBLIN, Nov. 22, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2023, which ended October 28, 2022.
Key Highlights
Revenue of $7.6 billion decreased 3% as reported and increased 2% organicGAAP diluted EPS of $0.32 decreased 67%; non-GAAP diluted EPS of $1.30 decreased 2%Company updates guidance; expects... More